SCHEMBL21765914

SCHEMBL21765914

CCC(=O)N1CC2CN(C(=O)CC)CC2C1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 7/20 0.72
CHRNA3 P32297 7/20 0.72
CHRNA4 P43681 7/20 0.72
CHRNB4 P30926 5/20 0.72
CHRNA7 P36544 3/20 0.72
CHRNB3 Q05901 2/20 0.61
CHRNA6 Q15825 2/20 0.61
ALDH1A1 P00352 1/20 0.46
EPHX2 P34913 3/20 0.40
BLM P54132 1/20 0.38
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
EPHX1 P07099 1/20 0.35
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21765915 1.00 CHRNB2 (0.72) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL18498281 0.91 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL15932468 0.90 CHRNB2 (0.67) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL25075300 0.89 CHRNB2 (0.60) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL23343819 0.86 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL11773423 0.86 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL20343593 0.86 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL24745070 0.85 CHRNB2 (0.56) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL1462657 0.84 CHRNA4 (1.00) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL3283353 0.84 CHRNB2 (0.60) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020041270-A1 COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF FOG PHARMACEUTICALS, INC. (US) 2020-02-27 WO disclosed